CD48, together with CD40, IL-4, and/or IL-10 stimulation, CD48 crosslinked by Abs causes B cell aggregation, proliferation, differentiation, and/or release of IG. In neutrophils, similar CD48 activation leads to increased cytoplasmic calcium levels. In T lymphocytes CD48, it increased CD8 + T cell proliferation in human T cells by costimulation. Meanwhile, blocking CD48 impairs T cell proliferation, IL-2 synthesis, and receptor expression, as well as T cell receptor and cytoskeletal rearrangements. The interaction between CD48 and CD2 is particularly important in T-cell activation and the adhesion between T cells and antigen-presenting cells. The interaction between CD48 and CD244 mainly affects the activation of NK cells and CD8 + T effector cells.

At present, various drugs targeting CD48/SLAMF2 are constantly under development, and taking drugs alone or together with other products to treat diseases has become a new method and remarkable achievements have been made. CD48/SLAMF2 protein has shown important research value and application prospects in tumor biology, and drug research and development. With further research and technological advances, CD48/SLAMF2 protein products are also essential. Alpha Lifetech can provide CD48/SLAMF2 corresponding products and help each customer's research and development. Alpha Lifetech focuses on high-precision detection development and validation services to support drug screening and biosimilar discovery. Our detection methods, including ELISA, cell-based functional testing, and flow cytometry, have undergone rigorous sensitivity, specificity, and reproducibility testing. In addition to testing and development, our team also provides data analysis, scheme optimization, and cross-species reactivity testing to ensure reliable results.